skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,887  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: Database: Coronavirus Research Database remove Database: ProQuest One Psychology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Material Type:
Article 		Add to My Research

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

The Lancet, 2020-12, Vol.396 (10267), p.1979-1993 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32466-1 ;PMID: 33220855

Digital Resources/Online E-Resources

Citations Cited by
2
Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study
Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study
Material Type:
Article 		Add to My Research

Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study

British journal of psychiatry, 2021-06, Vol.218 (6), p.326-333 [Peer Reviewed Journal]

Copyright © The Authors 2020. Published by Cambridge University Press on behalf of The Royal College of Psychiatrists ;Copyright © The Authors 2020. Published by Cambridge University Press on behalf of The Royal College of Psychiatrists. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.stm-assoc.org/about-the-industry/coronavirus-2019-ncov/. ;2020. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Authors 2020 2020 The Authors ;ISSN: 0007-1250 ;EISSN: 1472-1465 ;DOI: 10.1192/bjp.2020.212 ;PMID: 33081860

Digital Resources/Online E-Resources

Citations Cited by
3
Emotional distress in young adults during the COVID-19 pandemic: evidence of risk and resilience from a longitudinal cohort study
Emotional distress in young adults during the COVID-19 pandemic: evidence of risk and resilience from a longitudinal cohort study
Material Type:
Article 		Add to My Research

Emotional distress in young adults during the COVID-19 pandemic: evidence of risk and resilience from a longitudinal cohort study

Psychological Medicine, 2022-04, Vol.52 (5), p.824-833 [Peer Reviewed Journal]

Copyright © The Author(s), 2020. Published by Cambridge University Press ;Copyright © The Author(s), 2020. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.stm-assoc.org/about-the-industry/coronavirus-2019-ncov/. ;2020. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 2020 The Author(s) ;ISSN: 0033-2917 ;EISSN: 1469-8978 ;DOI: 10.1017/S003329172000241X ;PMID: 32571438

Digital Resources/Online E-Resources

Citations Cited by
4
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Material Type:
Article 		Add to My Research

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

The Lancet, 2020-06, Vol.395 (10239), p.1763-1770 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31189-2 ;PMID: 32442528

Digital Resources/Online E-Resources

Citations Cited by
5
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Material Type:
Article 		Add to My Research

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial

The Lancet, 2020-06, Vol.395 (10240), p.1845-1854 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31208-3 ;PMID: 32450106

Digital Resources/Online E-Resources

Citations Cited by
6
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Material Type:
Article 		Add to My Research

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet, 2020-08, Vol.396 (10249), p.479-488 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31605-6 ;PMID: 32702299

Digital Resources/Online E-Resources

Citations Cited by
7
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Material Type:
Article 		Add to My Research

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

The Lancet, 2020-09, Vol.396 (10255), p.887-897 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31866-3 ;PMID: 32896291

Digital Resources/Online E-Resources

Citations Cited by
8
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Material Type:
Article 		Add to My Research

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

The Lancet, 2020-10, Vol.396 (10259), p.1335-1344 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32009-2 ;PMID: 32987007

Digital Resources/Online E-Resources

Citations Cited by
9
Injection fears and COVID-19 vaccine hesitancy
Injection fears and COVID-19 vaccine hesitancy
Material Type:
Article 		Add to My Research

Injection fears and COVID-19 vaccine hesitancy

Psychological Medicine, 2023-03, Vol.53 (4), p.1185-1195 [Peer Reviewed Journal]

Copyright © The Author(s), 2021. Published by Cambridge University Press ;Copyright © The Author(s), 2021. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.stm-assoc.org/about-the-industry/coronavirus-2019-ncov/. ;The Author(s) 2021 2021 The Author(s) ;ISSN: 0033-2917 ;EISSN: 1469-8978 ;DOI: 10.1017/S0033291721002609 ;PMID: 34112276

Digital Resources/Online E-Resources

Citations Cited by
10
Generalized anxiety and depressive symptoms in various age groups during the COVID-19 lockdown in Poland. Specific predictors and differences in symptoms severity
Generalized anxiety and depressive symptoms in various age groups during the COVID-19 lockdown in Poland. Specific predictors and differences in symptoms severity
Material Type:
Article 		Add to My Research

Generalized anxiety and depressive symptoms in various age groups during the COVID-19 lockdown in Poland. Specific predictors and differences in symptoms severity

Comprehensive psychiatry, 2021-02, Vol.105, p.152222-152222, Article 152222 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. The Authors ;ISSN: 0010-440X ;EISSN: 1532-8384 ;DOI: 10.1016/j.comppsych.2020.152222 ;PMID: 33388494

Full text available

Citations Cited by
11
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
Material Type:
Article 		Add to My Research

Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

New England Journal of Medicine, 2022-05, Vol.386 (21), p.2011-2023 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2203315 ;PMID: 35544369

Digital Resources/Online E-Resources

Citations Cited by
12
Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic
Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic
Material Type:
Article 		Add to My Research

Increases in depression and anxiety symptoms in adolescents and young adults during the COVID-19 pandemic

Psychological Medicine, 2022-10, Vol.52 (14), p.3222-3230 [Peer Reviewed Journal]

Copyright © The Author(s) 2021. Published by Cambridge University Press ;Copyright © The Author(s) 2021. Published by Cambridge University Press. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.stm-assoc.org/about-the-industry/coronavirus-2019-ncov/. ;The Author(s) 2021 2021 The Author(s) ;ISSN: 0033-2917 ;EISSN: 1469-8978 ;DOI: 10.1017/S0033291720005358 ;PMID: 33436120

Digital Resources/Online E-Resources

Citations Cited by
13
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article 		Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

Citations Cited by
14
Early perceptions and behavioural responses during the COVID-19 pandemic: a cross-sectional survey of UK adults
Early perceptions and behavioural responses during the COVID-19 pandemic: a cross-sectional survey of UK adults
Material Type:
Article 		Add to My Research

Early perceptions and behavioural responses during the COVID-19 pandemic: a cross-sectional survey of UK adults

BMJ open, 2021-01, Vol.11 (1), p.e043577-e043577 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2020-043577 ;PMID: 33397669

Full text available

Citations Cited by
15
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age
Material Type:
Article 		Add to My Research

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

New England Journal of Medicine, 2022-11, Vol.387 (18), p.1673-1687 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2209367 ;PMID: 36260859

Digital Resources/Online E-Resources

Citations Cited by
16
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Material Type:
Article 		Add to My Research

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine, 2021-02, Vol.384 (5), p.403-416 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2035389 ;PMID: 33378609

Digital Resources/Online E-Resources

Citations Cited by
17
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Material Type:
Article 		Add to My Research

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine, 2020-12, Vol.383 (27), p.2603-2615 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034577 ;PMID: 33301246

Digital Resources/Online E-Resources

Citations Cited by
18
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients
Material Type:
Article 		Add to My Research

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

New England Journal of Medicine, 2022-02, Vol.386 (6), p.509-520 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116044 ;PMID: 34914868

Digital Resources/Online E-Resources

Citations Cited by
19
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Material Type:
Article 		Add to My Research

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

New England Journal of Medicine, 2021-06, Vol.384 (23), p.2187-2201 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2101544 ;PMID: 33882225

Digital Resources/Online E-Resources

Citations Cited by
20
Clinical Characteristics of Coronavirus Disease 2019 in China
Clinical Characteristics of Coronavirus Disease 2019 in China
Material Type:
Article 		Add to My Research

Clinical Characteristics of Coronavirus Disease 2019 in China

New England Journal of Medicine, 2020-04, Vol.382 (18), p.1708-1720 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2002032 ;PMID: 32109013

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 2,887  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (2,873)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2005  (6)
  2. 2005 To 2011  (3)
  3. 2012 To 2014  (13)
  4. 2015 To 2018  (25)
  5. After 2018  (2,841)
  6. More options open sub menu

Resource Type 

  1. Articles  (2,885)
  2. Reviews  (2)
  3. More options open sub menu

Language 

  1. English  (2,886)
  2. Japanese  (151)
  3. Portuguese  (21)
  4. Norwegian  (9)
  5. Spanish  (8)
  6. Polish  (3)
  7. Russian  (1)
  8. French  (1)
  9. Italian  (1)
  10. Croatian  (1)
  11. Lithuanian  (1)
  12. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait